In today’s high-stakes pharma environment, where supply chain risks, rising tariffs, and time-to-market pressures dominate, ...

Pharmageddon,' a documentary directed by Donal O'Neill and produced by cardiologist Aseem Malhotra, was launched recently at ...

Just as importantly, Serialization 2.0 enables better decision-making across the enterprise by unlocking data trapped in ...

The General Pharmaceutical Council (GPhC) enlisted Bond Bryan to transform a modern office into a dynamic, efficient ...

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

After consideration of two hundred and seventy-seven entries in eleven categories, the judges have decided on the finalists in this year’s ...

Indeed, in 2008, only 21 new drugs were approved for marketing in the United States, which is well below the level required to secure the future of the pharmaceutical industry. With the aim of ...

boosting efficiency for storage and retrieval in a fast-moving pharma industry. A challenging supply chain outlook As pharmaceutical regulations diverge internationally, logistics providers must take ...

John Armstrong, the Executive Vice President of LPC, said: "CMS Laser holds a significant market position in the pharmaceutical industry, offering superior technologies for high-volume pill ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The defendant contended that trademarks in the pharmaceutical industry are often derived from the drug’s active ingredient, in this case, Bilastine. Since the plaintiff’s and defendant’s marks were ...

The manufacturing pathway for a specialist synthetic active pharmaceutical ingredient (API ... and if we could translate these into a production scale,” explains Pietro Allegrini, R&D director at ...